Detection of oncogenic mutations in the EGFR gene in lung adenocarcinoma with 
differential sensitivity to EGFR tyrosine kinase inhibitors

Thomas, Roman K.; Greulich, Heidi; Yuza, Yuki; Lee, Jeff C.; Tengs, Torstein; Feng, Wei; Chen, Tzu-Hsiu; Nickerson, Elizabeth; Simons, Jan; Egholm, Michael; Rothberg, Jonathan M.; Sellers, William R.; Meyerson, Matthew L.

doi:10.1101/sqb.2005.70.056

Lokale TagsFreigabegeschichteDetailsÜbersicht

Detection of oncogenic mutations in the EGFR gene in lung adenocarcinoma with differential sensitivity to EGFR tyrosine kinase inhibitors

Thomas, R. K., Greulich, H., Yuza, Y., Lee, J. C., Tengs, T., Feng, W., et al. (2005). Detection of oncogenic mutations in the EGFR gene in lung adenocarcinoma with differential sensitivity to EGFR tyrosine kinase inhibitors. Cold Spring Harbor Symposia on Quantitative Biology, 70, 73-81. doi:10.1101/sqb.2005.70.056.

Item is Freigegeben

einblenden: alle ausblenden: alle

Basisdaten

einblenden: ausblenden:

Datensatz-Permalink: https://hdl.handle.net/11858/00-001M-0000-0026-D3C3-4 Versions-Permalink: https://hdl.handle.net/11858/00-001M-0000-0026-D3C4-2

Genre: Zeitschriftenartikel

ausblenden:

Urheber:
Thomas, Roman K.¹, Autor
Greulich, Heidi, Autor
Yuza, Yuki, Autor
Lee, Jeff C., Autor
Tengs, Torstein, Autor
Feng, Wei, Autor
Chen, Tzu-Hsiu, Autor
Nickerson, Elizabeth, Autor
Simons, Jan, Autor
Egholm, Michael, Autor
Rothberg, Jonathan M., Autor
Sellers, William R., Autor
Meyerson, Matthew L., Autor

Affiliations:
1Funktionelle Krebsgenomforschung, Junior Research Groups, Max-Planck-Institut für neurologische Forschung, Managing Director: D. Yves von Cramon, Max Planck Institute for Metabolism Research, Managing Director: Jens Brüning, Max Planck Society, ou_2149656